洞察市场格局
解锁药品研发情报

客服电话

400-9696-311

医药数据查询

【ChiCTR2100049315】DBT in Hong Kong Mental Health Community Setting

查看原文

立即下载

基本信息

登记号

ChiCTR2100049315

试验状态

正在进行

药物名称

药物类型

规范名称

首次公示信息日的期

2021-07-30

临床申请受理号

靶点

适应症

Borderline Personality Disorder; Pervasive dysregulation (e.g., behavioral, emotional, relational, etc.) with functional impairment in at least one domain (e.g., work, family, relationship, etc.)

试验通俗题目

DBT in Hong Kong Mental Health Community Setting

试验专业题目

The Effectiveness of Dialectical Behavior Therapy in a Mental Health Community Setting in Hong Kong

申办单位信息

申请人联系人

请登录查看

申请人名称

请登录查看

联系人邮箱

请登录查看

联系人邮编

联系人通讯地址

请登录查看

临床试验信息

试验目的

Dialectical Behavior Therapy (DBT) is an evidence-based treatment for individuals with symptoms of different psychiatric diagnoses (e.g., Cristea et al., 2017), particular those at risks for suicide or parasuicidal behavior (e.g., DeCou et al., 2019; Stanley et al., 2007) and those reporting emotion dysregulation (e.g., Kells et al., 2020). A transdiagnostic treatment that meets the needs of clinical populations at various risk levels can potentially mitigate the associated high cost to the health system as a whole. Considering the various components of DBT, establishment of a standard DBT program can be a multi-phasic project. Stand-alone DBT skills training groups have been found effective in reducing symptoms of mental health disorders (Valentine et al., 2014) and strengthening emotion regulation (Kells et al., 2020). Therefore, this study serves as a pilot and focuses on the effectiveness of skills training groups. Preliminary data collected will not only inform the projects subsequent phase(s) of expansion into a standard DBT program but also shed light on the implementation of DBT in an outpatient community setting in Hong Kong.

试验分类

请登录查看

试验类型

单臂

试验分期

Ⅲ期

随机化

N/A

盲法

N/A

试验项目经费来源

Lump sum grant

试验范围

目标入组人数

实际入组人数

第一例入组时间

2021-07-14

试验终止时间

2026-03-31

是否属于一致性

入选标准

- Aged 18 years or up; - Speak, read, and write Chinese; - Meet diagnostic criteria of Borderline Personality Disorder; OR show traits of pervasive dysregulation (e.g., behavioral, emotional, relational, etc.) with functional impairment in at least one domain (e.g., work, family, relationship, etc.); - Present treatment needs related to Stage 1 treatment targets as defined in DBT, such as life-threatening concerns, therapy-interfering behaviors, quality-of-life-interfering behaviors; - Show elevation on screening measures such as the Borderline Symptom List 23 (BSL-23).；

排除标准

- Present with active psychosis without insight; - Demonstrate sub-average intelligence; - Decline to commit on Stage 1 treatment targets; that is, targets related to areas such as life-threatening concerns, therapy-interfering behaviors, quality-of-life-interfering behaviors; - Concurrently receive other psychological services.；

研究者信息

研究负责人姓名

请登录查看

试验机构

新生活精神康復協會

研究负责人电话

请登录查看

研究负责人邮箱

请登录查看

研究负责人邮编

联系人通讯地址

请登录查看